Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis.
Giannini E, Borro P, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romagnoli P, Testa E, Risso D, Lantieri PB, Antonucci A, Boccato M, Milone S, Testa R.
Giannini E, et al. Among authors: lantieri pb.
Int J Biol Markers. 2000 Jul-Sep;15(3):226-30. doi: 10.1177/172460080001500304.
Int J Biol Markers. 2000.
PMID: 11012098
Free article.